Search research articles
Contact Us
Filters
Showing results (151-160 of 265) with videos related to
Page
of 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
Ralf Gutzmer, Anika Koop, Friedegund Meier, et al.
Scientific Reports
|
September 1, 2025
Distinct liver sections exhibit sex-specific gene expression patterns in Lewis rats
Luisa Sophie Rajcsanyi, Simge Oral, Julia Borgardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B
Annette Paschen, Antje Sucker, Bettina Hill, et al.
Pigment Cell Research
|
July 11, 2006
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Keith S Hoek, Natalie C Schlegel, Patricia Brafford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up
Selma Ugurel, Thomas Mentzel, Jochen Utikal, et al.
Oncotarget
|
April 6, 2017
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
Ioana Cosgarea, Selma Ugurel, Antje Sucker, et al.
Cancer Research
|
August 4, 2004
Immunogenicity of constitutively active V599EBRaf
Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2021
Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer: A retrospective analysis of 47 cases
Cindy Franklin, Axel Wetter, Hideo Andreas Baba, et al.
Cancer Immunology, Immunotherapy : CII
|
December 1, 2017
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC
Jürgen C Becker, Andreas Stang, Axel Zur Hausen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2017
PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
Katrin Schaper-Gerhardt, Steven Okoye, Rudolf Herbst, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 265) with videos related to
Sort By:
Page
of 27
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
Ralf Gutzmer, Anika Koop, Friedegund Meier, et al.
Scientific Reports
|
September 1, 2025
Distinct liver sections exhibit sex-specific gene expression patterns in Lewis rats
Luisa Sophie Rajcsanyi, Simge Oral, Julia Borgardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2009
Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B
Annette Paschen, Antje Sucker, Bettina Hill, et al.
Pigment Cell Research
|
July 11, 2006
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Keith S Hoek, Natalie C Schlegel, Patricia Brafford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up
Selma Ugurel, Thomas Mentzel, Jochen Utikal, et al.
Oncotarget
|
April 6, 2017
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
Ioana Cosgarea, Selma Ugurel, Antje Sucker, et al.
Cancer Research
|
August 4, 2004
Immunogenicity of constitutively active V599EBRaf
Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2021
Computed tomography-guided biopsy of radiologically unclear lesions in advanced skin cancer: A retrospective analysis of 47 cases
Cindy Franklin, Axel Wetter, Hideo Andreas Baba, et al.
Cancer Immunology, Immunotherapy : CII
|
December 1, 2017
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC
Jürgen C Becker, Andreas Stang, Axel Zur Hausen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2017
PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
Katrin Schaper-Gerhardt, Steven Okoye, Rudolf Herbst, et al.
Page
of 27